drugset / Trial / NCT07490327
Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia
Phase 1/2
Not yet recruiting
30 enrolled
Moogene Medi Co., Ltd
Seoul National University Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a randomized, open-label phase 1/2a study designed to evaluate the pharmacokinetics, pharmacodynamics, and safety of AD-303A (topical formulation) and AD-3031 in male patients with androgenetic alopecia. The study aims to compare pharmacological characteristics and safety profiles to support dose selection for further clinical development.
Timeline
- Start
- 2026-04
- Primary completion
- 2026-09
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AD-3031 | Unknown | — | Oral |
| Subject | AD-303A | Unknown | — | Topical |